These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16564922)

  • 41. Nuclear maspin detection in renal cell tumours: possible diagnostic role and correlation with p53 status.
    Blandamura S; Giacomelli L; Leo G; Segato P; Ninfo V
    Histopathology; 2006 Sep; 49(3):274-82. PubMed ID: 16918974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glypican-3 is expressed in chromophobe renal cell carcinomas.
    Okoń K
    Pol J Pathol; 2008; 59(1):15-20. PubMed ID: 18655366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Garcia E; Li M
    Am J Clin Pathol; 2006 Mar; 125(3):392-8. PubMed ID: 16613342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vinculin: its possible use as a marker of normal collecting ducts and renal neoplasms with collecting duct system phenotype.
    Kuroda N; Naruse K; Miyazaki E; Hayashi Y; Yoshikawa C; Ashida S; Moriki T; Yamasaki Y; Numoto S; Yamamoto Y; Yamasaki I; Hiroi M; Shuin T; Enzan H
    Mod Pathol; 2000 Oct; 13(10):1109-14. PubMed ID: 11048805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.
    Lidgren A; Hedberg Y; Grankvist K; Rasmuson T; Bergh A; Ljungberg B
    Eur Urol; 2006 Dec; 50(6):1272-7. PubMed ID: 16814458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemistry for the differential diagnosis of renal tumors with oncocytic features.
    Fernández-Aceñero MJ; Cazorla A; Manzarbeitia F
    Urol Oncol; 2011; 29(5):545-9. PubMed ID: 19926310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma.
    Chuang ST; Patton KT; Schafernak KT; Papavero V; Lin F; Baxter RC; Teh BT; Yang XJ
    J Urol; 2008 Feb; 179(2):445-9. PubMed ID: 18076934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma.
    Ingold B; Wild PJ; Nocito A; Amin MB; Storz M; Heppner FL; Moch H
    Histopathology; 2008 May; 52(6):674-81. PubMed ID: 18393979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renin expression in adult renal epithelial tumors with granular cells.
    Arias LF; Bruneval P; Blanco J
    Pathol Res Pract; 2010 Nov; 206(11):731-4. PubMed ID: 20619546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of bcl-2 oncoprotein in renal cell tumours.
    Paraf F; Gogusev J; Chrétien Y; Droz D
    J Pathol; 1995 Nov; 177(3):247-52. PubMed ID: 8551386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas.
    Wu SL; Kothari P; Wheeler TM; Reese T; Connelly JH
    Mod Pathol; 2002 Jul; 15(7):712-7. PubMed ID: 12118108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alpha-methyl CoA racemase expression in renal cell carcinomas.
    Molinié V; Balaton A; Rotman S; Mansouri D; De Pinieux I; Homsi T; Guillou L
    Hum Pathol; 2006 Jun; 37(6):698-703. PubMed ID: 16733210
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cathepsin H expression distinguishes oncocytomas from renal cell carcinomas.
    Castrén JP; Kamel DE; Nurmi MJ; Collan YU
    Anticancer Res; 2000; 20(1B):537-40. PubMed ID: 10769721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
    Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
    Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nuclear morphometry as a tool of limited capacity for distinguishing renal oncocytoma from chromophobe carcinoma.
    Okoń K; Sińczak-Kuta A
    Pol J Pathol; 2008; 59(1):9-13. PubMed ID: 18655365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpression of glutathione s-transferase alpha in clear cell renal cell carcinoma.
    Chuang ST; Chu P; Sugimura J; Tretiakova MS; Papavero V; Wang K; Tan MH; Lin F; Teh BT; Yang XJ
    Am J Clin Pathol; 2005 Mar; 123(3):421-9. PubMed ID: 15716239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
    Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C
    J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oncocytic papillary renal cell carcinoma with solid architecture: mimic of renal oncocytoma.
    Mai KT; Kohler DM; Robertson SJ; Belanger EC; Marginean EC
    Pathol Int; 2008 Mar; 58(3):164-8. PubMed ID: 18251779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.